United States · Bill · HR
H.R. 738 (105th)
Myelogram-Related Arachnoiditis Amendments of 1997
Introduced
12 February 1997
Last action
—
Status
Referred to the Subcommittee on Health and Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Myelogram-Related Arachnoiditis Amendments of 1997 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a myelogram involving the use of Pantopaque, Amipaque, Omipacque, or Isovue. Amends the Public Health Service Act to require a study and research with respect to individuals who have undergone a myelogram and who have subsequently developed arachnoiditis.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 12 February 1997
Introduced in House (PDF)
Introduced in House · EN · 12 February 1997
Introduced in House
summary · EN · 12 February 1997
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/105th-congress/house-bill/738
- Open data entity: https://api.congress.gov/v3/bill/105/hr/738